Update on statins

Intensive and Critical Care Nursing

Volumn 20, Issue 1, 2004, Pages 53-55

  Mason, Paula ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; CHOLESTEROL; FIBRIC ACID DERIVATIVE; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COA REDUCTASE INHIBITORS; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ION EXCHANGE RESIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID DERIVATIVE; PLACEBO; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLASSIFICATION; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; DRUG MONITORING; DRUG USE; EVIDENCE BASED MEDICINE; HEART INFARCTION; HEART PROTECTION; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; INCIDENCE; ISCHEMIC HEART DISEASE; MORTALITY; NATIONAL HEALTH SERVICE; PATIENT SELECTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRACTICE GUIDELINE; PRIMARY PREVENTION; SECONDARY PREVENTION; STROKE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 1642504363     PISSN: 09643397     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iccn.2003.10.006     Document Type: Article

References (9)

1. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
2. Law MR, et al. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systemic review and meta-analysis. BMJ 2003;326:1423-9.
3. LIPID Study Group. Prevention of cardiovascular events and death with pravastatin in patients with CHD and a broad range of initial cholesterol levels. New Engl J Med 1998;339:1349-57.
4. National Service Framework for Coronary Heart Disease. Department of Health; 2000. Available at www.doh.gov.uk/ nsf/coronary.htm.
5. Sacks FM, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels (CARE). New Engl J Med 1996;335:1001-9.
6. Scandinavian Simvastatin Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
7. Schneck DW, et al. Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolmaemia and without active arterial disease. Am J Cardiol 2003;91:33-41.
8. Sever PS, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA). Lancet 2003;361:1149-58.
9. Shepherd J, et al. Prevention of coronary heart disease with pravastatin in men with hypercholestaemia (WOSCOPS). New Engl J Med 1995;333:1301-7.